Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial
<p>Background</p> Findings from the RESTART trial suggest that starting antiplatelet therapy might reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding antiplatelet therapy. Brain imaging features of intracerebral haemorrhage and cerebral small vessel...
Main Authors: | Salman, R, Minks, DP, Mitra, D, Rodrigues, MA, Bhatnagar, P, Du Plessis, JC, Joshi, Y, Dennis, MS, Murray, GD, Newby, DE, Sandercock, PAG, Sprigg, N, Stephen, J, Sudlow, CLM, Werring, DJ, Whiteley, WN, Wardlaw, JM, White, PM, Restart Collaboration, Armitage, J |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
Elsevier
2019
|
Registos relacionados
-
The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial
Por: Salman, R, et al.
Publicado em: (2018) -
Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial
Por: Baigent, C, et al.
Publicado em: (2019) -
The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial
Por: Rustam Al-Shahi Salman, et al.
Publicado em: (2018-03-01) -
The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: statistical analysis plan for a randomised controlled trial
Por: Rustam Al-Shahi Salman, et al.
Publicado em: (2019-03-01) -
Cerebral Amyloid Angiopathy and Intracerebral Haemorrhage
Por: David Werring, et al.
Publicado em: (2016-09-01)